WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient"

Transcription

1 DEMENTIA

2 WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of aging Different from normal cognitive lapses Slide 2

3 THE EPIDEMIOLOGY OF ALZHEIMER S DISEASE 6% 8% of people age 65+ have AD Nearly 30% of those aged 85+ have AD Slide 3

4 Millions of people THE EPIDEMIOLOGY OF ALZHEIMER S DISEASE (AD) (1 of 2) Present Est by million in U.S. currently 14 million in U.S. by 2050 Life expectancy of 8 10 years after symptoms begin Slide 4

5 Economic THE IMPACT OF DEMENTIA $100 billion annually for care and lost productivity Medicare, Medicaid, private insurance provide only partial coverage Families bear greatest burden of expense Emotional Direct toll on patients Nearly half of caregivers suffer depression Slide 5

6 RISK FACTORS FOR DEMENTIA Definite Age Down syndrome Family history APOE4 allele Possible Head injury Fewer years of education Late onset of major depression Cardiovascular risk factors Slide 6

7 POSSIBLE PROTECTIVE FACTORS NSAIDs Antioxidants Statins Physical activity Intellectual activity Slide 8

8 THE GENETICS OF DEMENTIA Mutations of chromosomes 1, 14, 21 Rare early-onset (before age 60) familial forms of dementia Down syndrome Apolipoprotein E4 on chromosome 19 Late-onset AD APOE*4 allele risk & onset age in doserelated fashion APOE*2 allele may have protective effect Slide 8

9 Cognitive Evaluation Memory: rep statements, misplacing items, stm, ltm, immediate recall Language: speech fluency, comprehension, reading, writing, word finding, content of speech Visual spatial function: getting lost, driving Executive Functioning: planning, flexibility, organization, multistep tasks Personality/ Behavior: apathy, agitation, depression, hallucinations, delusions Motor: gait, falls, temor, weakness, coordination Attention Slide 9

10 ASSESSMENT: HISTORY Ask both the patient & a reliable informant about the patient s: Current condition Medical history Current medications & medication history Patterns of alcohol use or abuse Living arrangements Slide 10

11 ASSESSMENT: PHYSICAL Examine: Neurologic status Mental status Functional status Include: Quantified screens for cognition eg, Folstein s MMSE, Mini-Cog Neuropsychologic testing Slide 11

12 ASSESSMENT: LABORATORY Blood chemistries CBC Liver function tests Urinalysis Serologic tests for: RPR TSH Vitamin B 12 level Folate level

13 ASSESSMENT: BRAIN IMAGING Consider imaging when: Onset occurs at age <65 years Symptoms have occurred for <2 years Neurologic signs are asymmetric or focal Clinical picture suggests normal-pressure hydrocephalus Patient has had recent fall or other head trauma Consider: Noncontrast computed topography head scan Magnetic resonance imaging Positron emission tomography Slide 13

14 Normal aging DIFFERENTIAL DIAGNOSIS Mild cognitive impairment Delirium Depression Alzheimer s disease Vascular (multi-infarct) dementia Dementia associated with Lewy bodies Other (alcohol, Parkinson's disease, Pick s disease, frontal lobe dementia, neurosyphilis) Slide 14

15 NORMAL AGING No consistent, progressive deviations on testing of memory Some decline in processing and recall of new information: slower, harder Reminders work visual tips, notes Absence of significant effects on ADLs or IADLs due to cognition Slide 15

16 MILD COGNITIVE IMPAIRMENT Memory problem without deficits in other domains No functional impairment 12% per year progress to Alzheimer s disease Slide 16

17 DELIRIUM vs DEMENTIA Delirium and dementia often occur together in older hospitalized patients; the distinguishing signs of delirium are: Acute onset Cognitive fluctuations over hours or days Impaired consciousness and attention Altered sleep cycles Slide 17

18 DEPRESSION vs DEMENTIA (1 of 2) The symptoms of depression and dementia often overlap: Impaired concentration Lack of motivation, loss of interest, apathy Psychomotor retardation Sleep disturbance Slide 18

19 DEPRESSION vs DEMENTIA (2 of 2) Patients with primary depression are generally unlike those with dementia in that they: Demonstrate motivation during cognitive testing Express cognitive complaints that exceed measured deficits Maintain language and motor skills Effective treatment of depressive symptoms may improve cognition Slide 19

20 Onset: gradual ALZHEIMER S DISEASE Cognitive symptoms: primarily memory with difficulty learning new information Motor symptoms: rare early, apraxia later Progression: gradual, over 8 10 yr on average Lab tests: normal Imaging: possible global atrophy, small hippocampal volumes Slide 20

21 AD Cognitive Symptoms Begins with memory and spreads to include language and visual-spatial areas Lack of insight into deficits ( anasognosia) Apraxia: difficulty performing motor tasks develops later Executive function: most evident in middle and late stages Neuropsychiatric: common in middle and late, but apathy may be seen early Slide 21 20% of AD patients may present atypically with nonmemory complaints such as word finding, organizational or navigational problems

22 Alzheimers Disease PATH FINDINGS: - Neuritic plaque: amyloid - Neurofibrillary tangles: tau protein correlates more with cognitive decline than does amyloid plaque AUTOPSY: most severe pathology is found in the hippocampus, temporal cortex, and nucleus basalis of Meynert BIOCHEMICALLY: decrease in acetylcholine, choline acetyltransferase and nicotinic cholinergic receptors Slide 22

23 DSM-IV DIAGNOSTIC CRITERIA FOR AD Development of cognitive deficits manifested by: Impaired memory and Aphasia, apraxia, agnosia, disturbed executive function Significantly impaired social, occupational function Gradual onset, continuing decline Not due to CNS or other physical conditions (eg, PD, delirium) Not due to an Axis I disorder (eg, schizophrenia) Slide 23

24 LEWY BODY DEMENTIA Onset: gradual Cognitive symptoms: memory, visuospatial, hallucinations, fluctuations Motor symptoms: parkinsonism Progression: gradual, but usually faster than AD Lab tests: normal Imaging: possible global atrophy Slide 24

25 VASCULAR DEMENTIA Onset: may be sudden/stepwise Cognitive symptoms: depend on anatomy of ischemia Motor symptoms: correlates with ischemia Progression: stepwise with further ischemia Lab tests: normal Imaging: cortical or subcortical changes on MRI Slide 25

26 DSM-IV DIAGNOSTIC CRITERIA FOR VASCULAR DEMENTIA Development of cognitive deficits manifested by: Impaired memory and Aphasia, apraxia, agnosia, disturbed executive function Significantly impaired social, occupational function Focal neurologic symptoms & signs or evidence of cerebrovascular disease Deficits occur in absence of delirium Slide 26

27 FRONTOTEMPORAL DEMENTIA Onset: gradual, usually age <60 Cognitive symptoms: executive: disinhibition, apathy, behavior changes Motor symptoms: none; may be associated with ALS in rare cases Progression: gradual but faster than AD Lab tests: normal Imaging: atrophy in frontal and temporal lobes Slide 27

28 Less Common Causes of Dementia Vitamin deficiencies: B1 (WK), B12 Endocrine: thyroid AI, Cushings, Hypperparathryoidism Organ failure: renal, liver Chronic infections: HIV, Papovavirus ( ML), CJD, Tuberculosis, Fungal, Protozoal, NS Head trauma/diffuse brain damage: subdural, postencephalitis, NPH Neoplastic: primary, metastatic, paraneoplastic Slide 28 limbic encephalitis, meningeal carcinomatosis

29 Less Common Causes of Dementia Toxic: alcohol, drug, heavy metal Psychiatric Deg disorders: Huntington s disease, ALS, Downs Miscellaneous: sarcoidosis, vasculitis, recurrent nonconvulsive seizures Metabolic disorders: Wilson s disease, mitochondrial dysfunction Slide 29

30 NONPHARMACOLOGIC MANAGEMENT Cognitive rehabilitation Individual and group therapy Physical and mental activity Regular appointments Family and caregiver education and support Environmental modification Attention to safety Slide 30

31 PHARMACOLOGIC MANAGEMENT Treatment should be individualized Cholinesterase inhibitors: donepezil, rivastigmine, galantamine Memantine Other cognitive enhancers Antidepressants Psychoactive medications Slide 31

32 CHOLINESTERASE INHIBITORS Slow breakdown of acetylcholine Clinical trials demonstrate modest delay in cognitive decline compared with placebo GI side effects common No evidence of difference in efficacy among drugs Slide 32

33 MEMANTINE Neuroprotective effect is to reduce glutamatemediated excitotoxicity Modest benefit on cognition, ADLs, and behavior FDA-approved for moderate to severe AD Common adverse events: Constipation Dizziness Headache Slide 33

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey ALZHEIMER S DISEASE Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey Topics Covered Demography Clinical manifestations Pathophysiology Diagnosis Treatment Future trends Prevalence and Impact

More information

Delirium & Dementia. Nicholas J. Silvestri, MD

Delirium & Dementia. Nicholas J. Silvestri, MD Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts

More information

Assessing and Managing the Patient with Cognitive Decline

Assessing and Managing the Patient with Cognitive Decline Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor

More information

Mild Cognitive Impairment

Mild Cognitive Impairment Mild Cognitive Impairment James Y Lin, DO, MHSA Program Director, LIGHT (GWEP) VP Senior Services & Adult Living Medical Director, LECOM Senior Living Center Director, LECOM Institute for Successful Aging

More information

Dementia. Types of Dementia. Dementing Disorders. Concepts in the Evolution of Alzheimer s Disease and Treatment Approaches. Criteria for dementia:

Dementia. Types of Dementia. Dementing Disorders. Concepts in the Evolution of Alzheimer s Disease and Treatment Approaches. Criteria for dementia: Concepts in the Evolution of and Treatment Approaches Arnold Bakker, Ph.D. Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Dementia Criteria for dementia: Memory

More information

Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer s is the most common form of dementia.

Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer s is the most common form of dementia. CHAPTER 3 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer s is the most common form of dementia. This incurable, degenerative, terminal disease

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

Old Age and Stress. Disorders of Aging and Cognition. Disorders of Aging and Cognition. Chapter 18

Old Age and Stress. Disorders of Aging and Cognition. Disorders of Aging and Cognition. Chapter 18 Disorders of Aging and Cognition Chapter 18 Slides & Handouts by Karen Clay Rhines, Ph.D. Northampton Community College Comer, Abnormal Psychology, 8e Disorders of Aging and Cognition Dementia deterioration

More information

Diagnosis and Management of Mild Cognitive Impairment and Dementia in the Primary Care Setting. Meg Skibitsky MD, MPH Neurosciences Clinical Program

Diagnosis and Management of Mild Cognitive Impairment and Dementia in the Primary Care Setting. Meg Skibitsky MD, MPH Neurosciences Clinical Program Diagnosis and Management of Mild Cognitive Impairment and Dementia in the Primary Care Setting Meg Skibitsky MD, MPH Neurosciences Clinical Program Objectives Understand the difference between mild cognitive

More information

Dementia and cognitive decline

Dementia and cognitive decline Dementia and cognitive decline Expert Briefing Su Ray and Dr Susan Davidson Research Department Together, we can help everyone to love later life 01 Brain basics Normal ageing, cognitive impairment and

More information

Dementia is not normal aging!

Dementia is not normal aging! The Future of Alzheimer s Disease Treatment Adam L. Boxer, MD, PhD Director, Alzheimer s Disease Clinical Trials Program Memory and Aging Center Assistant Professor of Neurology University of California,

More information

Dementia: It s Not Always Alzheimer s

Dementia: It s Not Always Alzheimer s Dementia: It s Not Always Alzheimer s A Caregiver s Perspective Diane E. Vance, Ph.D. Mid-America Institute on Aging and Wellness 2017 My Background Caregiver for my husband who had Lewy Body Dementia

More information

Palliative Approach to the Person with Advanced Dementia

Palliative Approach to the Person with Advanced Dementia Mid North Coast Rural Palliative Care Project Link Nurse Education 2004 Palliative Approach to the Person with Advanced Dementia Anne Sneesby CNC - ACAT To care for the dying is a very human opportunity

More information

Dementia and Delirium

Dementia and Delirium Dementia and Delirium LPT Gondar Mental Health Group www.le.ac.uk Dementia and Delirium WTINP Chapter 4.6 Introduction - areas to be covered Delirium Definition and causes Clinical features Management

More information

Delirium, Dementia, and Amnestic Disorders. Dr.Al-Azzam 1

Delirium, Dementia, and Amnestic Disorders. Dr.Al-Azzam 1 Delirium, Dementia, and Amnestic Disorders Dr.Al-Azzam 1 Introduction Disorders in which a clinically significant deficit in cognition or memory exists The number of people with these disorders is growing

More information

Section Objectives. Module 4: Introduction to ID and Dementia. What is the difference between ID and dementia? 12/13/2017

Section Objectives. Module 4: Introduction to ID and Dementia. What is the difference between ID and dementia? 12/13/2017 Module 4: Introduction to ID and Dementia Matthew P. Janicki, Ph.D. mjanicki@uic.edu 1 Section Objectives Participants will be able to: Identify how dementia may appear different in adults with ID. Apply

More information

MCI and Dementia. Gerontechnology, Normal Cognitive Aging Process. Aging does not equate to loss of all cognitive abilities

MCI and Dementia. Gerontechnology, Normal Cognitive Aging Process. Aging does not equate to loss of all cognitive abilities MCI and Dementia Gerontechnology, 2016 Normal Cognitive Aging Process Aging does not equate to loss of all cognitive abilities Commonly Certain held misconception cognitive domains normally decline with

More information

Roger E. Kelley, M.D. Professor and Chairman Department of Neurology Tulane University School of Medicine New Orleans, Louisiana

Roger E. Kelley, M.D. Professor and Chairman Department of Neurology Tulane University School of Medicine New Orleans, Louisiana Roger E. Kelley, M.D. Professor and Chairman Department of Neurology Tulane University School of Medicine New Orleans, Louisiana FINANCIAL DISCLOSURE No potential conflict of interest to disclose. OBJECTIVES

More information

Chapter 94 Delirium and Dementia Episode Overview

Chapter 94 Delirium and Dementia Episode Overview Chapter 94 Delirium and Dementia Episode Overview Core questions: 1. List the four key diagnostic criteria for delirium. 2. List six strong predisposing or precipitating factors for delirium. 3. List 15

More information

EPIDEMIOLOGY AND SOCIETAL IMPACT

EPIDEMIOLOGY AND SOCIETAL IMPACT CHAPTER 17 DEMENTIA EPIDEMIOLOGY AND SOCIETAL IMPACT GENETIC AND OTHER RISK FACTORS DIFFERENTIAL DIAGNOSIS OF DEMENTIA ASSESSMENT METHODS AGITATION TREATMENT AND MANAGEMENT ANNOTATED REFERENCES Dementia

More information

Your Role in Dementia Detection and Treatment: An Interdisciplinary Approach

Your Role in Dementia Detection and Treatment: An Interdisciplinary Approach Your Role in Dementia Detection and Treatment: An Interdisciplinary Approach MaineHealth Concepts in Common: Communication Strategies to Improve Care For Hospitalized Elders Objectives Define and understand

More information

The Psychopharmacology of Alzheimer s Disease. Bruce Kaster, MD Instructor in Psychiatry Harvard Medical school

The Psychopharmacology of Alzheimer s Disease. Bruce Kaster, MD Instructor in Psychiatry Harvard Medical school The Psychopharmacology of Alzheimer s Disease Bruce Kaster, MD Instructor in Psychiatry Harvard Medical school Overview of Alzheimer s Disease Alzheimer s is a progressive degenerative disease Prevalence

More information

A BRIEF LOOK AT DEMENTIA

A BRIEF LOOK AT DEMENTIA Dementia A BRIEF LOOK AT DEMENTIA David Kaufman, MD Neurology Consultants of Bellin Health November 2, 2017 Defined as a progressive decline in cognitive function that impairs daily activities. Always

More information

Chapter 15: Late Life and Psychological Disorders

Chapter 15: Late Life and Psychological Disorders \ Chapter 15: Late Life and Psychological Disorders 1. Ageism refers to a. the physical deterioration that accompanies old age. b. the intellectual deterioration that frequently occurs as a person ages.

More information

Cognitive Assessment 4/29/2015. Learning Objectives To be able to:

Cognitive Assessment 4/29/2015. Learning Objectives To be able to: Supporting the Desire to Age in Place: Important Considerations for the Aging Population AGENDA 8:45 9:00 AM Geriatric Principles Robert L. Kane, MD *9:00 9:55 AM Cognitive Assessments Ed Ratner, MD 10:00

More information

Mental Health Disorders Civil Commitment UNC School of Government

Mental Health Disorders Civil Commitment UNC School of Government Mental Health Disorders 2017 Civil Commitment UNC School of Government Edward Poa, MD, FAPA Chief of Inpatient Services, The Menninger Clinic Associate Professor, Baylor College of Medicine NC statutes

More information

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/alzheimers-disease-towards-earlier-detection/latest-methods-earlydetection-alzheimers-cognitive-assessments-and-diagnostic-tools-practice/8321/

More information

Alzheimer s disease is an

Alzheimer s disease is an Alzheimer s Disease FACT SHEET Alzheimer s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest

More information

Mild Cognitive Impairment or Mild Neurocognitive Disorder: Implications for Clinical Practice. Hypothesized Key Players in the Pathogenesis of AD

Mild Cognitive Impairment or Mild Neurocognitive Disorder: Implications for Clinical Practice. Hypothesized Key Players in the Pathogenesis of AD AD is a Neurodegenerative Disease as Seen in the PET Scan and is Characterized by Amyloid Plaques and Neurofibrillary Tangles Mild Cognitive Impairment or Mild Neurocognitive Disorder: Implications for

More information

Subject Index. Band of Giacomini 22 Benton Visual Retention Test 66 68

Subject Index. Band of Giacomini 22 Benton Visual Retention Test 66 68 Subject Index Adams, R.D. 4 Addenbrooke s Cognitive Examination 101 Alzheimer s disease clinical assessment histological imaging 104 neuroimaging 101 104 neuropsychological assessment 101 clinical presentation

More information

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia 86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile

More information

Neuropsychological Testing (NPT)

Neuropsychological Testing (NPT) Neuropsychological Testing (NPT) POLICY Psychological testing (96101-03) refers to a series of tests used to evaluate and treat an individual with emotional, psychiatric, neuropsychiatric, personality

More information

Confronting the Clinical Challenges of Frontotemporal Dementia

Confronting the Clinical Challenges of Frontotemporal Dementia Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask

More information

Alzheimer s Diagnostic Basics For Mental Health Professionals

Alzheimer s Diagnostic Basics For Mental Health Professionals Alzheimer s Diagnostic Basics For Mental Health Professionals 1 CE Hour By: Kathryn Brohl, MA, LMFT Learning objectives List the possible causes of Alzheimer s disease. Describe diagnostic methods for

More information

What is Neuropsychology?

What is Neuropsychology? Alzheimer s Disease Neurological Bases and Informed Behavioral Interventions Peter T. Keenan Clinical Neuropsychologist Marshfield Clinic Minocqua Center What is Neuropsychology? Science of the relationship

More information

Plan for Today. Brain Injury: 8/4/2017. Effective Services for People Living with Brain Injury. What is it & what causes it?

Plan for Today. Brain Injury: 8/4/2017. Effective Services for People Living with Brain Injury. What is it & what causes it? Effective Services for People Living with Brain Injury Jean Capler, MSW, LSW Local Support Network Leader The Rehabilitation Hospital of Indiana Department of Resource Facilitation Plan for Today Brain

More information

Prof Tim Anderson. Neurologist University of Otago Christchurch

Prof Tim Anderson. Neurologist University of Otago Christchurch Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral

More information

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview

More information

Objectives. My Patient: The story 10/6/2017

Objectives. My Patient: The story 10/6/2017 Objectives Our Grey Matter Matters: A Case in Point Vivien Brown MDCM, CCFP,FCFP, NCMP Assistant Professor, University of Toronto Vice President, Medical Affairs, Medisys Healthy Group Past President,

More information

Dementia. Presented By Jennifer L. Nanson

Dementia. Presented By Jennifer L. Nanson Dementia Presented By Jennifer L. Nanson Dementia QuickTime and a decompressor are needed to see this picture. Dementia: Current Definition DSM-IV-TR Does not imply a prognosis Refers to a framework of

More information

Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends

Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends ASSESSING COMPETENCE Michael A Hill MD UNC Psychiatry 2008 Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives,

More information

Mild Cognitive Impairment

Mild Cognitive Impairment Mild Cognitive Impairment Victor W. Henderson, MD, MS Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences Stanford University Director, Stanford Alzheimer s

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: diagnosis and assessment bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.

More information

Organic mental disorders

Organic mental disorders Organic mental disorders F00-F09 Organic, including symptomatic, mental disorders This block comprises a range of mental disorders grouped together on the basis of their having in common a demonstrable

More information

#CHAIR2015. Miami, Florida. September 24 26, JW Marriott Miami. Sponsored by

#CHAIR2015. Miami, Florida. September 24 26, JW Marriott Miami. Sponsored by #CHAIR2015 September 24 26, 2015 JW Marriott Miami Miami, Florida Sponsored by Case Challenge Workshop Alzheimer s Disease Anand Kumar, MD University of Illinois at Chicago, College of Medicine Chicago,

More information

Mild cognitive impairment A view on grey areas of a grey area diagnosis

Mild cognitive impairment A view on grey areas of a grey area diagnosis Mild cognitive impairment A view on grey areas of a grey area diagnosis Dr Sergi Costafreda Senior Lecturer Division of Psychiatry, UCL Islington Memory Service, C&I NHS FT s.costafreda@ucl.ac.uk London

More information

Cognitive Decline: Memory Loss, Alzheimer s, & Dementia - Update 2015

Cognitive Decline: Memory Loss, Alzheimer s, & Dementia - Update 2015 Cognitive Decline: Memory Loss, Alzheimer s, & Dementia - Update 2015 Andrew E. Budson, M.D. Chief, Cognitive & Behavioral Neurology, and Director, Center for Translational Cognitive Neuroscience Veterans

More information

Epilepsy in dementia. Case 1. Dr. Yotin Chinvarun M..D. Ph.D. 5/25/16. CEP, PMK hospital

Epilepsy in dementia. Case 1. Dr. Yotin Chinvarun M..D. Ph.D. 5/25/16. CEP, PMK hospital Epilepsy in dementia Dr. Yotin Chinvarun M..D. Ph.D. CEP, PMK hospital Case 1 M 90 years old Had a history of tonic of both limbs (Lt > Rt) at the age of 88 years old, eye rolled up, no grunting, lasting

More information

Title of Course: The Dementias: Hope through Research CE Credit: 1 Hour Learning Level: Intermediate Author: National Institute on Aging

Title of Course: The Dementias: Hope through Research CE Credit: 1 Hour Learning Level: Intermediate Author: National Institute on Aging Title of Course: The Dementias: Hope through Research CE Credit: 1 Hour Learning Level: Intermediate Author: National Institute on Aging Course Abstract: A diagnosis of dementia can be frightening for

More information

Clinical Research on Treating Senile Dementia by Combining Acupuncture with Acupoint-Injection

Clinical Research on Treating Senile Dementia by Combining Acupuncture with Acupoint-Injection Clinical Research on Treating Senile Dementia by Combining Acupuncture with Acupoint-Injection Yemeng Chen, M.D. Acupuncture Department, Huashan Hospital Shanghai Medical University, Shanghai 20040, P.

More information

MANAGING YOUR COGNITIVE SYMPTOMS. Dr. Valerie Suski University of Pittsburgh Medical Center HDSA COE Director

MANAGING YOUR COGNITIVE SYMPTOMS. Dr. Valerie Suski University of Pittsburgh Medical Center HDSA COE Director MANAGING YOUR COGNITIVE SYMPTOMS Dr. Valerie Suski University of Pittsburgh Medical Center HDSA COE Director The information provided by speakers in workshops, forums, sharing/networking sessions and any

More information

2016 Programs & Information

2016 Programs & Information Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia

More information

MANAGEMENT OF PATIENT WITH DEMENTIA SSA PERSPECTIVE

MANAGEMENT OF PATIENT WITH DEMENTIA SSA PERSPECTIVE MANAGEMENT OF PATIENT WITH DEMENTIA SSA PERSPECTIVE Njideka U. Okubadejo, MBChB, FMCP Associate Professor & Consultant Neurologist College of Medicine, University of Lagos, & Lagos University Teaching

More information

PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW

PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW TMH Professionals, LLC, American College of Psychotherapy & LPCA present PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW Module 7: Differential Diagnosis, Scope of Practice,

More information

BEHAVIORAL PROBLEMS IN DEMENTIA

BEHAVIORAL PROBLEMS IN DEMENTIA BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and

More information

A Neurologist s Approach to Altered Mental Status

A Neurologist s Approach to Altered Mental Status A Neurologist s Approach to Altered Mental Status S. Andrew Josephson, MD Department of Neurology University of California San Francisco October 23, 2008 The speaker has no disclosures Case 1 A 71 year-old

More information

Clinical Manifestations of Neuropsychiatric Disorders

Clinical Manifestations of Neuropsychiatric Disorders Clinical Manifestations of Neuropsychiatric Disorders Koho Miyoshi and Yasushi Morimura Abstract Cerebral disorders commonly cause psychiatric symptoms. It is recommended to call psychiatric symptoms or

More information

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci.

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci. How to Diagnose Early (Prodromal) Lewy Body Dementia Ian McKeith MD, FRCPsych, F Med Sci. Parkinson s Disease Lewy Body Disease Time PD Dementia Lewy Body Dementias Dementia with Lewy Bodies (DLB) Diagnostic

More information

Introduction to the diagnosis of dementia

Introduction to the diagnosis of dementia Introduction to the diagnosis of dementia Serge Gauthier and Pedro Rosa-Neto This chapter will outline general strategies to establish the presence and the differential diagnosis of dementia, and the case

More information

Caring Sheet #13: Frontotemporal Dementia:

Caring Sheet #13: Frontotemporal Dementia: CARING SHEETS: Caring Sheet #13: Frontotemporal Dementia: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet

More information

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH EADC BRUNO VELLAS 14/01/05 10:14 Page 1 EADC OVERVIEW B. VELLAS & E. REYNISH (Toulouse, France, EU) Bruno Vellas: The European Alzheimer's Disease Consortium is a European funded network of centres of

More information

Introduction to Dementia Care

Introduction to Dementia Care Introduction to Dementia Care Dementia Care Training Kit Updated February 4, 2011 Care and Compliance Group, Inc 800.321.1727 www.careandcompliance.com INTRODUCTION Fundamental Precepts of Good Dementia

More information

Anosognosia, or loss of insight into one s cognitive

Anosognosia, or loss of insight into one s cognitive REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and

More information

What is dementia? Symptoms. alzheimers.org.uk

What is dementia? Symptoms. alzheimers.org.uk alzheimers.org.uk What is dementia? This factsheet explains what dementia is, including the causes and symptoms, and how it is diagnosed and treated. It also looks at some of the different types of dementia.

More information

Substance and Medication Induced Mood Disorders KELLY GODECKE, MD PSYCHIATRY DEPARTMENT UNIVERSITY OF UTAH

Substance and Medication Induced Mood Disorders KELLY GODECKE, MD PSYCHIATRY DEPARTMENT UNIVERSITY OF UTAH Substance and Medication Induced Mood Disorders KELLY GODECKE, MD PSYCHIATRY DEPARTMENT UNIVERSITY OF UTAH Substance Induced Depressive Disorder A. A prominent and persistent disturbance in mood that predominates

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer

More information

American Medical Association, American Academy of Neurology Institute and American Psychiatric Association (2016)

American Medical Association, American Academy of Neurology Institute and American Psychiatric Association (2016) Source(s) American Medical Association, American Academy of Neurology Institute and American Psychiatric Association (2016) Measure Domain Communication and Care Coordination: Process Brief Abstract Description

More information

SYNOPSIS. Trial No.: RIS-USA-70 Clinical phase: III. JRF, Clinical Research Report RIS-USA-70, 16 October, 1998 N Trial period: Start: 20 Nov 95

SYNOPSIS. Trial No.: RIS-USA-70 Clinical phase: III. JRF, Clinical Research Report RIS-USA-70, 16 October, 1998 N Trial period: Start: 20 Nov 95 SYNOPSIS Trial identification and protocol summary Company: Janssen Research Foundation Finished product: RISPERDAL Active ingredient: Risperidone (R064,766) Title: An open-label, long-term study of risperidone

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

Pharmacological Treatment of Dementia

Pharmacological Treatment of Dementia Pharmacological Treatment of Dementia Measure Description Percentage of patients with dementia or their caregivers with whom available guideline-appropriate pharmacological treatment options and nonpharmacological

More information

Jacinta Lucke Resident Emergency Medicine PHD Gerontology & Geriatrics

Jacinta Lucke Resident Emergency Medicine PHD Gerontology & Geriatrics Jacinta Lucke Resident Emergency Medicine PHD Gerontology & Geriatrics TAKE HOME MESSAGE When managing confusion in older patients: Routinely screen for impaired cognition Patients with impaired cognition

More information

Healthy Aging and Reducing the Risk of Alzheimer s disease in People with Down syndrome

Healthy Aging and Reducing the Risk of Alzheimer s disease in People with Down syndrome Healthy Aging and Reducing the Risk of Alzheimer s disease in People with Down syndrome Elizabeth Head, Ph.D. Department of Pharmacology & Nutritional Sciences Sanders-Brown Center on Aging University

More information

The child with hemiplegic cerebral palsy thinking beyond the motor impairment. Dr Paul Eunson Edinburgh

The child with hemiplegic cerebral palsy thinking beyond the motor impairment. Dr Paul Eunson Edinburgh The child with hemiplegic cerebral palsy thinking beyond the motor impairment Dr Paul Eunson Edinburgh Content Coming to a diagnosis The importance of understanding the injury MRI scans Role of epilepsy

More information

Dementia: Managing Difficult Behaviors. No conflicts of interest. Off-label medication use will be discussed during this talk.

Dementia: Managing Difficult Behaviors. No conflicts of interest. Off-label medication use will be discussed during this talk. Dementia: Managing Difficult Behaviors No conflicts of interest. Off-label medication use will be discussed during this talk. 1 Types of Neurocognitive Disorder Alzheimer s Disease Vascular Frontotemporal

More information

Neurology Goals: Knowledge:

Neurology Goals: Knowledge: Neurology Goals: A solid understanding of normal neurological development, anatomy and neurophysiology is imperative to the treatment of neurological pathology. The goal is to sensitize the family medicine

More information

Scams: Influencing the Aging Brain

Scams: Influencing the Aging Brain Neuropsychology: study of the brain and how it relates to cognition, emotion, and behavior Neuropsychological Assessment: a comprehensive evaluation of how the brain is functioning. Examines cognitive

More information

2018 ALZHEIMER S DISEASE FACTS AND FIGURES. Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis

2018 ALZHEIMER S DISEASE FACTS AND FIGURES. Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis 2018 ALZHEIMER S DISEASE FACTS AND FIGURES Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis About this report 2018 Alzheimer s Disease Facts and Figures is a statistical

More information

What is dementia? alzheimers.org.uk

What is dementia? alzheimers.org.uk alzheimers.org.uk What is dementia? If you, or a friend or relative, have been diagnosed with dementia, you may be feeling anxious or confused. You may not know what dementia is. This factsheet should

More information

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association Claims & Underwriting Alzheimer s & Cognitive Impairment: You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association 1 OVERVIEW Impact

More information

Neurosyphilis SYPHILIS OF THE CENTRAL NERVOUS SYSTEM AS A CAUSE OF COGNITIVE IMPAIRMENT AT YOUNGER AGE, DIAGNOSTIC DIFFICULTIES

Neurosyphilis SYPHILIS OF THE CENTRAL NERVOUS SYSTEM AS A CAUSE OF COGNITIVE IMPAIRMENT AT YOUNGER AGE, DIAGNOSTIC DIFFICULTIES 29 SYPHILIS OF THE CENTRAL NERVOUS SYSTEM AS A CAUSE OF COGNITIVE IMPAIRMENT AT YOUNGER AGE, DIAGNOSTIC DIFFICULTIES Nesteruk M 1 *, Nesteruk T 2, Mandecka M 3, Dorobek M 1 1. Neurology Clinic, MSW Hospital,

More information

Geriatrics and Cancer Care

Geriatrics and Cancer Care Geriatrics and Cancer Care Roger Wong, BMSc, MD, FRCPC, FACP Postgraduate Dean of Medical Education Clinical Professor, Division of Geriatric Medicine UBC Faculty of Medicine Disclosure No competing interests

More information

A Personal Guide to Organic Brain Disorders

A Personal Guide to Organic Brain Disorders A Personal Guide to Organic Brain Disorders What is Dementia? Dementia is the decline of cognitive functions of sufficient severity to interfere with two or more of a person s daily living activities.

More information

Dementia, Assessment, and Caregiver Resources

Dementia, Assessment, and Caregiver Resources Dementia, Assessment, and Caregiver Resources Susan F. Randhawa, M.S.W., L.C.S.W. UCI Institute for Memory Impairments and Neurological Disorders with special thanks to: Malcolm B. Dick, Ph.D. & Cordula

More information

1 in 3 seniors dies with Alzheimer s or another dementia.

1 in 3 seniors dies with Alzheimer s or another dementia. 2013 Alzheimer s disease facts and figures Includes a Special Report on long-distance caregivers 1 in 3 seniors dies with Alzheimer s or another dementia. Out-of-pocket expenses for long-distance caregivers

More information

Pain in dementia. Prof Rowan Harwood Geriatrician, NUH. Disclaimer

Pain in dementia. Prof Rowan Harwood Geriatrician, NUH. Disclaimer Pain in dementia Prof Rowan Harwood Geriatrician, NUH Disclaimer Pain What is pain? Pain Pain is what the patient says it is McCaffery 1968 Pain An unpleasant sensory or emotional experience associated

More information

DEMENTIA AND MEDICATION

DEMENTIA AND MEDICATION DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,

More information

Dementia is defined as the development of multiple. Presenile Dementia Etiology, Clinical Profile and Treatment Response at Four Month Follow Up

Dementia is defined as the development of multiple. Presenile Dementia Etiology, Clinical Profile and Treatment Response at Four Month Follow Up Original Article Presenile Dementia Etiology, Clinical Profile and Treatment Response at Four Month Follow Up U Sundar*, A Sharma**, ME Yeolekar*** Abstract Dementia is the development of multiple cognitive

More information

Alzheimer's Disease, Prevalence, and Caregiving

Alzheimer's Disease, Prevalence, and Caregiving Alzheimer's Disease, Prevalence, and Caregiving Specific information in this year s Alzheimer s Disease Facts and Figures includes: Proposed guidelines for diagnosing Alzheimer s disease from the National

More information

ASA/NCOA April 15, 2004 Internal Causes of Falls: Falls Prevention from the Ground UP

ASA/NCOA April 15, 2004 Internal Causes of Falls: Falls Prevention from the Ground UP ASA/NCOA April 15, 2004 Internal Causes of Falls: Falls Prevention from the Ground UP Steven Charles Castle, M.D. Clinical Professor, UCLA Director of Geriatrics, VA Greater LA President, ElderCare Experts

More information

The Agitated. Older Patient: old. What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003

The Agitated. Older Patient: old. What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003 Focus on CME at Queen s University Focus on CME at Queen s University The Agitated The Older Patient: What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003 Both

More information

NCFE Level 2 Certificate in The Principles of Dementia Care

NCFE Level 2 Certificate in The Principles of Dementia Care The Principles of Dementia Care S A M P LE NCFE Level 2 Certificate in The Principles of Dementia Care Part A 1 These learning resources and assessment questions have been approved and endorsed by ncfe

More information

What is frontotemporal dementia?

What is frontotemporal dementia? What is frontotemporal dementia? Introduction Information in this introductory booklet is for anyone who wants to know more about frontotemporal dementia (FTD). This includes people living with FTD, their

More information